I

Inhibrx
D

INBX

74.250
USD
-3.16
(-4.08%)
مغلق
حجم التداول
12,243
الربح لكل سهم
-4
العائد الربحي
-
P/E
-6
حجم السوق
1,079,872,547
الأفكار والتحليلات
هشام منسي
هشام منسي
منذ 5 أشهر
buy
2025-09-22 05:39
INBX Chart
المزيد
المقالات

العنوان: Inhibrx Biosciences Inc.

القطاع: Healthcare
الصناعة: Biotechnology
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.